š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
The purpose of this study is to assess the 4-site "one-week" post-exposure ...
Status
Completed
Location
Multiple Locations
Start Date
2012-06-29
Trial ID
NCT01622062
Treatments Being Tested
Malaria is a disease that affects many people in Africa. Malaria is caused ...
Status
Completed
Location
University of Bamako, Malaria Research and Training Center
Start Date
2007-05
Trial ID
NCT00460525
Treatments Being Tested
A phase III clinical trial to evaluate the immunogenicity and safety of fre...
Status
Completed
Location
Changchun Zhuoyi Biological Co., Ltd
Start Date
2020-07-22
Trial ID
NCT05549908
Treatments Being Tested
To evaluate the safety and immunogenicity of high-titered ALVAC-HIV MN120TM...
Status
Completed
Location
UAB AVEG
Start Date
TBD
Trial ID
NCT00000847
Treatments Being Tested
A single center, prospective cohort, open-label study of rabies post exposu...
Status
Completed
Location
Faculty of Medicine, Siriraj Hospital, Mahidol University
Start Date
2015-03
Trial ID
NCT03093545
Treatments Being Tested
This study aims to investigate physicians' adherence to Advisory Committee ...
Status
Completed
Location
Faculty of Medicine Tanta university
Start Date
2025-06-01
Trial ID
NCT07012083
Treatments Being Tested
The study is planned as a single-center, randomized, double-blind placebo-c...
Status
Completed
Location
Multiple Locations
Start Date
2013-08
Trial ID
NCT02538185
The primary objective of this study is: To demonstrate the VRVg-2 is non-i...
Status
Completed
Location
Investigational Site Number : 7640001
Start Date
2019-10-21
Trial ID
NCT04127786
P27A study is designed as a randomized phase Ia/Ib trial to evaluate the sa...
Status
Completed
Location
CHUV CRC
Start Date
2014-03
Trial ID
NCT01949909
Treatments Being Tested
This study will evaluate the immunogenicity of rabies vaccine at 13 months,...
Status
Terminated
Location
Multiple Locations
Start Date
2010-01
Trial ID
NCT01067079
Treatments Being Tested